Concert Pharmaceuticals (NASDAQ:CNCE) Insider Buying and Selling Activity
Insider Ownership Percentage: 9.40%
Concert Pharmaceuticals (NASDAQ CNCE) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 6/10/2019 | Bvf Partners L P/Il | Major Shareholder | Sell | 386,289 | $10.70 | $4,133,292.30 | |  |
| 11/15/2018 | Richard Aldrich | Director | Buy | 50,000 | $11.83 | $591,500.00 | 296,975 | |
| 7/10/2018 | Nancy Stuart | COO | Sell | 31,418 | $17.87 | $561,439.66 | 116,085 | |
| 4/17/2018 | James V Cassella | Insider | Sell | 10,582 | $20.18 | $213,544.76 | 30,000 | |
| 2/1/2018 | Richard Aldrich | Director | Sell | 11,946 | $20.89 | $249,551.94 | 286,975 | |
| 1/29/2018 | Richard Aldrich | Director | Sell | 18,054 | $20.63 | $372,454.02 | 286,975 | |
| 1/26/2018 | Richard Aldrich | Director | Sell | 5,000 | $20.46 | $102,300.00 | 286,975 | |
| 1/24/2018 | Richard Aldrich | Director | Sell | 30,000 | $19.68 | $590,400.00 | 286,975 | |
| 1/22/2018 | Richard Aldrich | Director | Sell | 10,000 | $19.55 | $195,500.00 | 286,975 | |
| 1/19/2018 | Richard Aldrich | Director | Sell | 30,000 | $19.35 | $580,500.00 | 286,975 | |
| 1/16/2018 | Richard Aldrich | Director | Sell | 31,236 | $19.14 | $597,857.04 | 286,975 | |
| 12/19/2017 | Value Fund L P Biotechnology | Insider | Sell | 1,282,856 | $26.65 | $34,188,112.40 | | |
| 12/4/2017 | Ronald W Barrett | Director | Sell | 14,156 | $24.70 | $349,653.20 | 3,539 | |
| 10/19/2017 | Value Fund L P Biotechnology | Insider | Buy | 331,916 | $15.84 | $5,257,549.44 | | |
| 9/14/2017 | Ryan Lynch | Insider | Sell | 3,500 | $14.51 | $50,785.00 | 9,500 | |
| 5/12/2016 | Thomas G Auchincloss | Director | Buy | 2,000 | $10.11 | $20,220.00 | 2,000 | |
| 5/11/2016 | Roger D Tung | CEO | Buy | 19,610 | $10.55 | $206,885.50 | 538,965 | |
| 12/16/2015 | Wilfred E Jaeger | Director | Sell | 10,360 | $19.57 | $202,745.20 | | |
| 12/15/2015 | Wilfred E Jaeger | Director | Sell | 54,572 | $20.10 | $1,096,897.20 | | |
| 12/14/2015 | Pauline Mcgowan | VP | Sell | 498 | $20.07 | $9,994.86 | | |
| 12/14/2015 | Wilfred E Jaeger | Director | Sell | 3,922 | $20.09 | $78,792.98 | | |
| 11/9/2015 | Ronald W. Barrett | Director | Sell | 17,699 | $22.27 | $394,156.73 | | |
| 11/2/2015 | Nancy Stuart | COO | Sell | 23,216 | $24.29 | $563,916.64 | 25,004 | |
| 9/18/2015 | Robert Silverman | VP | Sell | 10,000 | $20.00 | $200,000.00 | 10,000 | |
| 9/10/2015 | Wilfred E Jaeger | Director | Sell | 120,000 | $18.22 | $2,186,400.00 | | |
| 8/18/2015 | Wilfred E Jaeger | Director | Sell | 760,000 | $15.81 | $12,015,600.00 | | |
| 8/13/2015 | Wilfred E Jaeger | Director | Sell | 92,215 | $16.75 | $1,544,601.25 | | |
| 8/12/2015 | Wilfred E Jaeger | Director | Sell | 97,785 | $17.49 | $1,710,259.65 | | |
| 6/8/2015 | Robert Silverman | VP | Sell | 5,000 | $16.35 | $81,750.00 | | |
| 3/11/2015 | Nancy Stuart | COO | Sell | 46,430 | $15.00 | $696,450.00 | | |
| 3/11/2015 | Pauline Mcgowan | VP | Sell | 5,973 | $16.00 | $95,568.00 | | |
| 3/10/2015 | Pauline Mcgowan | VP | Sell | 22,122 | $13.90 | $307,495.80 | | |
| 11/18/2014 | Three Arch Management Iv, L.L. | Director | Sell | 250,000 | $12.29 | $3,072,500.00 | | |
| 2/20/2014 | Skyline Venture Partners Quali | Major Shareholder | Buy | 150,000 | $14.00 | $2,100,000.00 | | |
| 2/19/2014 | Life Science Ventures Vi G Tvm | Director | Buy | 89,000 | $14.00 | $1,246,000.00 | | |
| 2/19/2014 | Plc Glaxosmithkline | Major Shareholder | Buy | 35,000 | $14.00 | $490,000.00 | | |
(Data available from 1/1/2013 forward)
